CTOs on the Move

Secura Bio

www.securabio.com

 
Secura Bio™ is a pharmaceutical company committed to giving patients access to innovative therapies. Headquartered in Henderson, Nevada, Secura Bio™ has operations in the U.S. and Offices in San Diego.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.securabio.com
  • 1887 Whitney Mesa Drive #1050
    Henderson, NV USA 89014
  • Phone: 858.251.1414

Executives

Name Title Contact Details

Funding

Secura Bio raised $55M on 03/05/2019
Secura Bio raised $90M on 03/05/2019

Similar Companies

Clever Leaves

Clever Leaves is a multi-national cannabis company with a mission to operate in compliance with federal and state laws and with an emphasis on ecologically sustainable, large-scale cultivation and pharmaceutical-grade processing as the cornerstones of its global cannabinoid business. With operations and investments in Canada, Colombia, Germany, Portugal, and the United States, Clever Leaves has created an effective distribution network and global footprint, with a foundation built upon capital efficiency and rapid growth. Clever Leaves aims to be one of the industry`s leading global cannabinoid companies recognized for its principles, people, and performance while fostering a healthier global community.

Modigene

Modigene Inc. is a Vienna, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hart Design Group

Hart Design Group is a Cumberland, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NVE Pharmaceuticals

NVE Pharmaceuticals is a Andover, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Delcath

Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The company`s proprietary percutaneous hepatic perfusion (PHP) system is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In the United States, the PHP system is being developed under the tradename HEPZATO KIT (melphalan hydrochloride for injection/hepatic delivery system), or HEPZATO, and is considered a combination drug and device product regulated by the United States Food and Drug Administration (FDA).